Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes of Cerebral Glucose Metabolism Associated With the Fear Network Activity Before and After 12 Weeks of Escitalpram Treatment in Panic Disorder

NCT00767871 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT00767871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00767871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes of Cerebral Glucose Metabolism Associated With the Fear Network Activity Before and After 12 Weeks of Escitalpram Treatment in Panic Disorder
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2007
Completion date
December 31, 2008
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

panic disorder